Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1MHW

Design of non-covalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides

Summary for 1MHW
Entry DOI10.2210/pdb1mhw/pdb
Related1CJL
Related PRD IDPRD_000270
DescriptorCathepsin L, 4-biphenylacetyl-Cys-(D)Arg-Tyr-N-(2-phenylethyl) amide, ... (4 entities in total)
Functional Keywordscathepsin l, cysteine protease, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourceHomo sapiens (human)
More
Cellular locationLysosome: P07711 P07711
Total number of polymer chains8
Total formula weight50780.57
Authors
Chowdhury, S.,Sivaraman, J.,Wang, J.,Devanathan, G.,Lachance, P.,Qi, H.,Menard, R.,Lefebvre, J.,Konishi, Y.,Cygler, M.,Sulea, T.,Purisima, E.O. (deposition date: 2002-08-21, release date: 2002-12-11, Last modification date: 2024-11-20)
Primary citationChowdhury, S.,Sivaraman, J.,Wang, J.,Devanathan, G.,Lachance, P.,Qi, H.,Menard, R.,Lefebvre, J.,Konishi, Y.,Cygler, M.,Sulea, T.,Purisima, E.O.
Design of non-covalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides
J.Med.Chem., 45:5321-5329, 2002
Cited by
PubMed Abstract: A novel series of noncovalent inhibitors of cathepsin L have been designed to mimic the mode of autoinhibition of procathepsin L. Just like the propeptide, these peptide-based inhibitors have a reverse-binding mode relative to a substrate and span both the S' and S subsites of the enzyme active site. In contrast to previous studies in which even moderate truncation of the full-length propeptide led to rapid reduction in potency, these blocked tripeptide-sized inhibitors maintain nanomolar potency. Moreover, these short peptides show higher selectivity (up to 310-fold) for inhibiting cathepsin L over K versus only 2-fold selectivity of the 96-residue propeptide of cathepsin L. A 1.9 A X-ray crystallographic structure of the complex of cathepsin L with one of the inhibitors confirms the designed reverse-binding mode of the inhibitor as well as its noncovalent nature. Enzymatic analysis also shows the inhibitors to be resistant to hydrolysis at elevated concentrations of the enzyme. The mode of inhibition of these molecules provides a general strategy for inhibiting other cathepsins as well as other proteases.
PubMed: 12431059
DOI: 10.1021/jm020238t
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon